Skip to content Skip to sidebar Skip to footer

Anne Li                                                                                               May 13th, 2017

 

MIT biologists have now identified a major switch that occurs as adenomas transition to adenocarcinomas in a mouse model of lung cancer. They've also discovered that blocking this switch prevents the tumors from becoming more aggressive. Drugs that interfere with this switch may thus be useful in treating early-stage lung cancers. The switch occurs when a small percentage of cells in the tumor begin acting like stem cells, allowing them to give rise to unlimited populations of new cancer cells.
 
See original article at: https://www.sciencedaily.com/releases/2017/05/170510132004.htm

Leave a comment